Entity Common Stock, Shares Outstanding of Astria Therapeutics, Inc. from 01 Aug 2015 to 31 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Astria Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Aug 2015 to 31 Oct 2025.
  • Astria Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 31 Oct 2025 was 57,084,838, a 1.2% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Astria Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 57,084,838 +650,619 +1.2% 31 Oct 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 56,434,894 +9,612 +0.02% 31 Jul 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 56,434,219 +1,521,158 +2.8% 30 Apr 2025 10-Q 13 May 2025 2025 Q1
Q3 2024 56,434,219 +20,138,028 +55% 31 Oct 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 56,425,282 +28,384,569 +101% 31 Jul 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 54,913,061 +26,926,343 +96% 30 Apr 2024 10-Q 09 May 2024 2024 Q1
Q3 2023 36,296,191 +19,470,433 +116% 31 Oct 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 28,040,713 +15,023,758 +115% 31 Jul 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 27,986,718 +14,969,763 +115% 17 Mar 2023 10-K 22 Mar 2023 2022 FY
Q3 2022 16,825,758 +3,816,281 +29% 31 Oct 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 13,016,955 -63,931,848 -83% 29 Jul 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 13,016,955 -10,400,051 -44% 04 Mar 2022 10-K 10 Mar 2022 2021 FY
Q3 2021 13,009,477 -7,074,860 -35% 01 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 76,948,803 +57,868,034 +303% 30 Jul 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 23,417,006 +5,519,834 +31% 04 Mar 2021 10-K/A 19 Apr 2021 2020 FY
Q3 2020 20,084,337 +8,287,145 +70% 30 Oct 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 19,080,769 +7,463,657 +64% 31 Jul 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 17,897,172 +6,401,430 +56% 02 Mar 2020 10-K 10 Mar 2020 2019 FY
Q3 2019 11,797,192 -59,241,227 -83% 31 Oct 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 11,617,112 -59,421,307 -84% 31 Jul 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 11,495,742 -17,539,760 -60% 07 Mar 2019 10-K 14 Mar 2019 2018 FY
Q3 2018 71,038,419 +47,955,242 +208% 31 Oct 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 71,038,419 +48,556,684 +216% 31 Jul 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 29,035,502 +10,136,955 +54% 07 Mar 2018 10-K 15 Mar 2018 2017 FY
Q3 2017 23,083,177 +4,430,874 +24% 31 Oct 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 22,481,735 +7,100,317 +46% 31 Jul 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 18,898,547 +3,562,214 +23% 08 Mar 2017 10-K 16 Mar 2017 2016 FY
Q3 2016 18,652,303 +3,354,509 +22% 31 Oct 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 15,381,418 +83,624 +0.55% 31 Jul 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 15,336,333 07 Mar 2016 10-K 15 Mar 2016 2015 FY
Q3 2015 15,297,794 01 Nov 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 15,297,794 01 Aug 2015 10-Q 13 Aug 2015 2015 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.